Trispecific Antibodies in Anticancer Immunotherapy

Ashley Goland ’23 Immunotherapy is a form of cancer treatment that utilizes the body’s own immune system to destroy cancerous tumors and has shown promise in past animal and clinical human trials. For all of its dazzling successes to date, however, immunotherapy is not completely effective for treating the full range of cancer types and patients— yet. Scientists working in Sanofi Research and Development believe … Continue reading Trispecific Antibodies in Anticancer Immunotherapy

Breast Cancer Metastasis Hypothesized to be Affected by Type of Administered Anesthesia

Simran Kaur ‘20 Complete surgical resection of breast tissue, known as a mastectomy, is often suggested as the first-line treatment in patients diagnosed with breast cancer. Metastasis, the spread of cancer cells to other parts of the body, is a frequent occurrence after surgery and is the primary cause of cancer-related deaths. It was hypothesized by the researchers in this study that the type of … Continue reading Breast Cancer Metastasis Hypothesized to be Affected by Type of Administered Anesthesia

Nanoparticles May Be the New Future for Cancer Immunotherapy

Gaurav Sharma ’22 Cancer immunotherapy has been extensively explored and requires information of the tumor’s antigen presentation in order for a method to be selected. An approach that is more effective and has a broader range had not been found that did not have the constraint of needing the information of the tumor’s antigen presentation. Researchers at Johns Hopkins School of Medicine and Johns Hopkins … Continue reading Nanoparticles May Be the New Future for Cancer Immunotherapy

Inactivated Gene Linked to Kidney Cancer and Tumor Development in Mice

Gaurav Sharma ’22 The epigenetic components pertaining to the onset of cancer have been of interest for many years due to the hope of developing approaches to delay the onset of cancer in the future for an individual. Recently, a tumor suppressor family has been discovered, called Ras-Association Domain Family (RASSF) which epigenetically inactivated breast, lung, skin, and thyroid cancers. Neither RASSF10’s in-vivo function nor … Continue reading Inactivated Gene Linked to Kidney Cancer and Tumor Development in Mice

After the Fall: Link Between PTSD and Prostate Cancer

Wendy Wu ’22 On the morning of September 11, 2001, the Twin Towers of the World Trade Center (WTC) collapsed. Within minutes, first responders arrived on the scene. Amidst the debris and smothering dust, they got to work, evacuating citizens and heading into the towers to rescue whoever they could. It was truly a display of heroic bravery and compassion, but unfortunately, many of the … Continue reading After the Fall: Link Between PTSD and Prostate Cancer

Application of Trispecific Antibodies to Anticancer Immunotherapy

Ashley Goland ’23 Immunotherapy is a form of cancer treatment that utilizes the body’s own immune system to destroy cancerous tumors and has shown promise in past animal and clinical human trials. For all of its dazzling successes to date, however, immunotherapy is not completely effective for treating the full range of cancer types and patients— yet. Scientists working in Sanofi Research and Development believe … Continue reading Application of Trispecific Antibodies to Anticancer Immunotherapy

Different Types of Anesthesia can Impact Breast Cancer Metastasis.

Priyanshi Patel ‘22 Metastasis refers to the surgical removal of solid tumors and metastasis is the main cause of cancer death. Previously, not much was known about the role anesthetics play in cancer metastasis. Complete surgical removal of solid tumors offers the possibility of a cure and is the basic treatment provided. Despite surgery, recurrent metastasis in vital organs does reoccur and is a major … Continue reading Different Types of Anesthesia can Impact Breast Cancer Metastasis.

Improved Body Composition After Testosterone Treatment in Young Male Cancer Survivors

Priyanshi Patel ’22 Young male cancer survivors have low testosterone levels compared to those of  healthy populations. Long term effects of low testosterone involve endocrine disorders that affect up to 50% of adult childhood cancer survivors, and younger survivors are often unsure as to whether they would benefit from testosterone treatment. A study was conducted in the United Kingdom on secondary hospital outpatients.. The study … Continue reading Improved Body Composition After Testosterone Treatment in Young Male Cancer Survivors

Biodiversity Offers Insight into the Ecosystem of Liver Cancer

Priyanshi Patel ’22 Liver cancer is the second most lethal malignancy in the world and includes mainly hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). HCC is the most common type of primary liver cancer and often occurs in people with chronic liver diseases. iCCA is also a cancer that develops within the bile duct, whereas HCC occurs among alcoholics or those with fat accumulation in … Continue reading Biodiversity Offers Insight into the Ecosystem of Liver Cancer

Potential for Enhanced Cancer Therapy by Allosteric Inhibition of Phosphoglycerate Mutase

Jorge Pincay ’20 Phosphoglycerate mutase 1 (PGAM1) is a gene known to promote rapid tumor growth and invasiveness in several cancers, including non-small cell lung cancer (NSCLC). PGAM1 encodes for an enzyme that catalyzes the conversion of 3-phosphoglycerate to 2-phosphoglycerate in the glycolytic pathway,  a compound that coordinates anabolic biosynthesis. In many forms of cancer, including NSCLC, urothelial bladder cancer, and hepatocellular carcinoma, upregulation of … Continue reading Potential for Enhanced Cancer Therapy by Allosteric Inhibition of Phosphoglycerate Mutase